Literature DB >> 8743190

The lysosomal granule membrane protein, LAMP-2, is also present in platelet dense granule membranes.

S J Israels1, E M McMillan, C Robertson, S Singhory, A McNicol.   

Abstract

Lysosomal Associated Membrane Protein-2 (LAMP-2) is an inherent component of lysosomal granule membranes in diverse cell types, including platelets. We examined platelets for evidence of LAMP-2 in dense granule membranes as CD63 has previously been shown to be present in both lysosomal and dense granule membranes. Immunological techniques were used to examine the localization of LAMP-2 in control platelets and those from an individual with Hermansky-Pudlak syndrome (HPS), a condition characterised by platelet dense granule deficiency. Immunoblotting studies demonstrated that LAMP-2 was enriched in a dense granule preparation. Flow cytometry of thrombin-stimulated control platelets was consistent with biphasic surface expression of LAMP-2. The early expression was accompanied by dense granule, but minimal lysosomal granule, release. The late expression was accompanied by additional lysosomal granule release only. Thrombin stimulation of HPS platelets showed only late, lysosome-associated LAMP-2 expression. Immunoelectron microscopy indicated the presence of LAMP-2 in the membranes of serotonin-containing granules as identified by an anti-serotonin polyclonal antibody. These data indicate that LAMP-2 is present in the membranes of platelet dense granules in addition to lysosomal granules, and has a similar distribution to CD63.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8743190

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  7 in total

Review 1.  Molecular defects that affect platelet dense granules.

Authors:  Meral Gunay-Aygun; Marjan Huizing; William A Gahl
Journal:  Semin Thromb Hemost       Date:  2004-10       Impact factor: 4.180

Review 2.  Platelet "first responders" in wound response, cancer, and metastasis.

Authors:  David G Menter; Scott Kopetz; Ernest Hawk; Anil K Sood; Jonathan M Loree; Paolo Gresele; Kenneth V Honn
Journal:  Cancer Metastasis Rev       Date:  2017-06       Impact factor: 9.264

3.  Blood platelet and monocyte activations and relation to stages of liver cirrhosis.

Authors:  Anatol Panasiuk; Janusz Zak; Edwina Kasprzycka; Katarzyna Janicka; Danuta Prokopowicz
Journal:  World J Gastroenterol       Date:  2005-05-14       Impact factor: 5.742

4.  A mutation in Rab27a causes the vesicle transport defects observed in ashen mice.

Authors:  S M Wilson; R Yip; D A Swing; T N O'Sullivan; Y Zhang; E K Novak; R T Swank; L B Russell; N G Copeland; N A Jenkins
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

5.  Defective release of α granule and lysosome contents from platelets in mouse Hermansky-Pudlak syndrome models.

Authors:  Ronghua Meng; Jie Wu; Dawn C Harper; Yuhuan Wang; M Anna Kowalska; Charles S Abrams; Lawrence F Brass; Mortimer Poncz; Timothy J Stalker; Michael S Marks
Journal:  Blood       Date:  2014-12-04       Impact factor: 22.113

Review 6.  Platelets and cancer: a casual or causal relationship: revisited.

Authors:  David G Menter; Stephanie C Tucker; Scott Kopetz; Anil K Sood; John D Crissman; Kenneth V Honn
Journal:  Cancer Metastasis Rev       Date:  2014-03       Impact factor: 9.264

7.  Platelet subpopulations remain despite strong dual agonist stimulation and can be characterised using a novel six-colour flow cytometry protocol.

Authors:  Anna Linnea Södergren; Sofia Ramström
Journal:  Sci Rep       Date:  2018-01-23       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.